We work with forward-looking researchers to demonstrate the clinical value of our solutions to patients, clinicians and the risk-bearing payors such as health plans and accountable care organizations (ACOs) that support them.
Real-World-Data from our engagements reveals great health economic outcome potential and staggering acceptance
of their condition
ePS1.07 Patient experience of virtual consultations: survey results, Journal of Cystic Fibrosis Volume 19, Supplement 2, June 2020, Page s39
Hospitals, universities, pharma companies and CROs around the world have chosen NuvoAir as their respiratory partner. We’re proud to support the work of forward-thinking, innovative players and researchers.